SS
Sugandha Sunil Kubal
About Sugandha Sunil Kubal
Data last updated:
Sugandha Sunil Kubal is a Director at Aurazen Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Aurazen Pharmaceutical Private Limited reported revenue of ₹12.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aurazen Pharmaceutical Private Limited U24100MH2020PTC352076 | Director | 21 Aug 2023 | 2020 | ₹12.1 Lakh (FY 2025) | Active |
Board colleagues of Sugandha Sunil Kubal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rutuja Yatin Shelar | 08008291 | Aurazen Pharmaceutical Private Limited | Director |
| Shreeya Yatin Shelar | 09696735 | Aurazen Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sugandha Sunil Kubal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sugandha Sunil Kubal
Sugandha Sunil Kubal currently holds 1 directorship: Aurazen Pharmaceutical Private Limited (Director, since 21 Aug 2023, revenue ₹12.1 Lakh (FY 2025)).
Sugandha Sunil Kubal was first appointed on 21 Aug 2023 as Director at Aurazen Pharmaceutical Private Limited.
The current boards of Sugandha Sunil Kubal's companies include Rutuja Yatin Shelar (Aurazen Pharmaceutical Private Limited), Shreeya Yatin Shelar (Aurazen Pharmaceutical Private Limited).